N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression.

N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression.
复制标题

N-甲基 D-天冬氨酸受体亚型 2B 拮抗剂 Ro 25-6981 通过抑制突触后密度 95 表达来减轻神经性疼痛。

DOI:
10.1038/s41598-018-26209-7
复制
发表时间:
2018-05-18
期刊:
影响因子:
4.6
通讯作者:
Yao YX
Yao YX
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Huang LE;Guo SH;Thitiseranee L;Yang Y;Zhou YF;Yao YX

文献摘要

参考文献

被引文献

相似文献

突触后密度-95 (PSD-95)是一种突触支架蛋白,在神经性疼痛的发展中起着至关重要的作用。然而,其潜在机制尚不清楚。为了研究PSD-95在n -甲基- d -天冬氨酸受体亚型2B (NR2B)介导的慢性疼痛中的作用,我们利用大鼠坐骨神经慢性收缩损伤(CCI)模型研究了PSD-95的激活与NR2B功能之间的关系。我们发现,CCI动物脊髓背角中PSD-95总蛋白和cAMP反应元件结合蛋白(CREB)、磷酸化NR2B、PSD-95和CREB的表达水平以及NR2B与PSD-95的相互作用水平均有所增加。在热痛评估试验中,鞘内注射选择性NR2B拮抗剂Ro 25-6981增加了足爪戒断潜伏期。此外,Ro 25-6981反复处理可显著减轻热过敏,抑制cci诱导的脊髓背角PSD-95上调。此外,鞘内注射PSD-95抑制剂显著逆转了热痛和机械性痛觉过敏。我们的研究结果表明,阻断脊髓中NR2B信号可以作为治疗神经性疼痛的候选治疗方法。
Postsynaptic density-95 (PSD-95) is a synaptic scaffolding protein that plays a crucial role in the development of neuropathic pain. However, the underlying mechanism remains unclear. To address the role of PSD-95 in N-methyl-D-aspartate receptor subtype 2B (NR2B) -mediated chronic pain, we investigated the relationship between PSD-95 activation and NR2B function in the spinal cord, by using a rat model of sciatic nerve chronic constriction injury (CCI). We demonstrate that the expression levels of total PSD-95 and cAMP response element binding protein (CREB), as well as phosphorylated NR2B, PSD-95, and CREB, in the spinal dorsal horn, and the interaction of NR2B with PSD-95 were increased in the CCI animals. Intrathecal injection of the selective NR2B antagonist Ro 25-6981 increased paw withdrawal latency, in a thermal pain assessment test. Moreover, repeated treatment with Ro 25-6981 markedly attenuated the thermal hypersensitivity, and inhibited the CCI-induced upregulation of PSD-95 in the spinal dorsal horn. Furthermore, intrathecal injection of the PSD-95 inhibitor strikingly reversed the thermal and mechanical hyperalgesia. Our results suggest that blocking of NR2B signaling in the spinal cord could be used as a therapeutic candidate for treating neuropathic pain.
含有 NR2B 的脊髓 NMDA 受体在神经性疼痛发生中的作用
DOI: 10.1016/j.expneurol.2008.10.018
发表时间: 2009-02-01
影响因子: 5.3
作者:
Qu, Xiao-Xiu;Cai, Jie;Xing, Guo-Gang
通讯作者: Xing, Guo-Gang
DOI: 10.1016/0304-3940(95)11326-r
发表时间: 1995-02-24
影响因子: 2.5
作者:
EISENBERG, E;LACROSS, S;STRASSMAN, AM
通讯作者: STRASSMAN, AM
DOI: 10.1016/j.pain.2012.02.006
发表时间: 2012-05-01
期刊: PAIN
影响因子: 7.4
作者:
Peng, Hsien-Yu;Chen, Gin-Den;Lin, Tzer-Bin
通讯作者: Lin, Tzer-Bin
鞘内注射肽 Myr-NR2B9c 通过扰乱小鼠 N-甲基-D-天冬氨酸受体-PSD-95 蛋白相互作用减轻骨癌疼痛
DOI: 10.1213/ane.0000000000000202
发表时间: 2014-06-01
影响因子: 5.7
作者:
Liu, Yue;Cui, Xinlong;Gu, Xiaoping
通讯作者: Gu, Xiaoping
神经炎症驱动的慢性疼痛的新兴目标。
DOI: 10.1038/nrd4334
发表时间: 2014-07
影响因子: 120.1
作者:
Ji, Ru-Rong;Xu, Zhen-Zhong;Gao, Yong-Jing
通讯作者: Gao, Yong-Jing